123 related articles for article (PubMed ID: 3281332)
21. Comparison of autologous and allogeneic bone marrow transplantation for treatment of high-risk refractory acute lymphoblastic leukemia.
Kersey JH; Weisdorf D; Nesbit ME; LeBien TW; Woods WG; McGlave PB; Kim T; Vallera DA; Goldman AI; Bostrom B
N Engl J Med; 1987 Aug; 317(8):461-7. PubMed ID: 3302708
[TBL] [Abstract][Full Text] [Related]
22. Sources and sequelae of bacterial contamination of hematopoietic stem cell components: implications for the safety of hematotherapy and graft engineering.
Webb IJ; Coral FS; Andersen JW; Elias AD; Finberg RW; Nadler LM; Ritz J; Anderson KC
Transfusion; 1996 Sep; 36(9):782-8. PubMed ID: 8823450
[TBL] [Abstract][Full Text] [Related]
23. Bacterial contamination of autologous bone marrow during processing.
Farrington M; Matthews I; Jestice HK; Scott MA; Marcus RE; Hunt C; Foreman J
J Hosp Infect; 1996 Nov; 34(3):230-3. PubMed ID: 8923280
[No Abstract] [Full Text] [Related]
24. [Biocompatibility testing of different sterilised or disinfected allogenous bone grafts in comparison to the gold standard of autologous bone grafts--an "in vitro" analysis of immunomodulation].
Endres S; Kratz M; Heinz M; Herzberger C; Reichel S; von Garrel T; Gotzen L; Wilke A
Z Orthop Ihre Grenzgeb; 2005; 143(6):660-8. PubMed ID: 16380899
[TBL] [Abstract][Full Text] [Related]
25. Allogeneic and autologous bone marrow transplantation for acute nonlymphocytic leukemia.
Hurd DD
Semin Oncol; 1987 Dec; 14(4):407-15. PubMed ID: 3321445
[TBL] [Abstract][Full Text] [Related]
26. Microbial contamination of hematopoietic progenitor cell grafts-incidence, clinical outcome, and cost-effectiveness: an analysis of 735 grafts.
Kamble R; Pant S; Selby GB; Kharfan-Dabaja MA; Sethi S; Kratochvil K; Kohrt N; Ozer H
Transfusion; 2005 Jun; 45(6):874-8. PubMed ID: 15934984
[TBL] [Abstract][Full Text] [Related]
27. Cryopreservation of hematopoietic stem/progenitor cells for therapeutic use.
Watt SM; Austin E; Armitage S
Methods Mol Biol; 2007; 368():237-59. PubMed ID: 18080475
[TBL] [Abstract][Full Text] [Related]
28. Transfusion of bone marrow red cells during bone marrow harvests.
Rosenfeld CS; Tedrow HE; Bryan R; Mangan KF; Shadduck RK
Exp Hematol; 1988 Sep; 16(8):702-4. PubMed ID: 3042443
[TBL] [Abstract][Full Text] [Related]
29. The use of photodynamic therapy in bone marrow purging.
Mulroney CM; Glück S; Ho AD
Semin Oncol; 1994 Dec; 21(6 Suppl 15):24-7. PubMed ID: 7992104
[TBL] [Abstract][Full Text] [Related]
30. Bacterial infections in pediatric hematopoietic stem cell transplantation recipients: incidence, epidemiology, and spectrum of pathogens: report of the Polish Pediatric Group for Hematopoietic Stem Cell Transplantation.
Zając-Spychała O; Wachowiak J; Pieczonka A; Siewiera K; Frączkiewicz J; Kałwak K; Gorczyńska E; Chybicka A; Czyżewski K; Jachna-Sawicka K; Wysocki M; Klepacka J; Goździk J; Zaucha-Prażmo A; Kowalczyk JR; Styczyński J
Transpl Infect Dis; 2016 Oct; 18(5):690-698. PubMed ID: 27479544
[TBL] [Abstract][Full Text] [Related]
31. Infectious complications of human bone marrow transplantation.
Winston DJ; Gale RP; Meyer DV; Young LS
Medicine (Baltimore); 1979 Jan; 58(1):1-31. PubMed ID: 368507
[TBL] [Abstract][Full Text] [Related]
32. Allograft and autograft purging using immunotoxins in clinical bone marrow transplantation for hematologic malignancies.
Uckun FM; Myers DE
J Hematother; 1993; 2(2):155-63. PubMed ID: 7921971
[TBL] [Abstract][Full Text] [Related]
33. Impact of harvest product volume in erythrocyte depletion of allogeneic or autologous bone marrow using COBE spectra.
Soydan E; Ayyildiz E; Dalva K; Topçuoğlu P; Tol M; Arslan O; Ilhan O; Arat M
Transfus Apher Sci; 2007 Jun; 36(3):269-73. PubMed ID: 17574924
[TBL] [Abstract][Full Text] [Related]
34. Allogeneic bone marrow grafts with high levels of CD4(+) CD25(+) FoxP3(+) T cells can lead to engraftment failure.
Fricke S; Rothe K; Hilger N; Ackermann M; Oelkrug C; Fricke C; Schönfelder U; Niederwieser D; Emmrich F; Sack U
Cytometry A; 2012 Jun; 81(6):476-88. PubMed ID: 22522779
[TBL] [Abstract][Full Text] [Related]
35. Bacterial contamination rates following processing of bone marrow and peripheral blood progenitor cell preparations.
Padley D; Koontz F; Trigg ME; Gingrich R; Strauss RG
Transfusion; 1996 Jan; 36(1):53-6. PubMed ID: 8607154
[TBL] [Abstract][Full Text] [Related]
36. Automated processing of human bone marrow can result in a population of mononuclear cells capable of achieving engraftment following transplantation.
Areman EM; Cullis H; Spitzer T; Sacher RA
Transfusion; 1991 Oct; 31(8):724-30. PubMed ID: 1926317
[TBL] [Abstract][Full Text] [Related]
37. Rapid and safe automated processing of bone marrow grafts without using density gradient cryopreservation and transplantation.
Deméocq F; Kanold J; Bezou MJ; Travade P; Chassagne J; Berger M
Prog Clin Biol Res; 1994; 389():675-84. PubMed ID: 7700935
[No Abstract] [Full Text] [Related]
38. Bone marrow transplantation: current results in leukemia.
Santos GW
Yale J Biol Med; 1982; 55(5-6):477-85. PubMed ID: 6763816
[TBL] [Abstract][Full Text] [Related]
39. Influence of harvest bacterial contamination on autologous peripheral blood progenitor cells post-transplant.
Majado MJ; García-Hernández A; Morales A; González C; Martínez-Sánchez V; Menasalvas A; Rosique P; Rubio A; Sanz-Imedio E
Bone Marrow Transplant; 2007 Jan; 39(2):121-5. PubMed ID: 17173054
[TBL] [Abstract][Full Text] [Related]
40. CD34(+) hematopoietic progenitor cell selection of bone marrow grafts for autologous transplantation in pediatric patients.
Kasow KA; Sims-Poston L; Eldridge P; Hale GA
Biol Blood Marrow Transplant; 2007 May; 13(5):608-14. PubMed ID: 17448921
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
